Matches in SemOpenAlex for { <https://semopenalex.org/work/W3174221007> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- W3174221007 endingPage "P" @default.
- W3174221007 startingPage "1022" @default.
- W3174221007 abstract "Background: The number of people with diabetes-related end-stage renal disease (ESRD-DM) has doubled in the last two decades. We examined changes in excess mortality for people with ESRD-DM from 2002 onwards in the US and Australia. Methods: We included all adults (ages 20-84) receiving renal replacement therapy for ESRD-DM in the US (n = 1,178,860 from the United States Renal Data System, 2002-2017) and Australia (n = 10,380 from the Australia and New Zealand Dialysis and Transplant Registry, 2002-2013). Annual standardized mortality ratios (SMRs) were stratified by age, sex, race (US only), and treatment modality. Trends were assessed using Join point regression and annual percent change (APC) reported. Results: Overall, the SMR for ESRD-DM decreased from 2006-2013 in the US (from 11.4 to 9.5; APC: -2.5) and 2002-2013 in Australia (from 11.6 to 9.3; APC: -3.3). Differences by subgroup were noted, see Figure 1. Conclusions: Excess mortality for people with ESRD-DM has decreased in the US and Australia, but progress has stalled since 2013 in the US (comparative Australian data not available). Further, excess mortality remains more than nine times higher in ESRD-DM vs. the general population, with important variations by subgroups. Given the increasing burden of diabetes in the population, a focus on reducing excess mortality risk in the ESRD-DM population is needed. Disclosure J. L. Harding: None. J. I. Morton: None. J. E. Shaw: Advisory Panel; Self; Eli Lilly and Company, Merck Sharp & Dohme Corp., Pfizer Inc., Research Support; Self; AstraZeneca, Speaker’s Bureau; Self; AstraZeneca, Eli Lilly and Company, Novo Nordisk. D. J. Magliano: None." @default.
- W3174221007 created "2021-07-05" @default.
- W3174221007 creator A5024475260 @default.
- W3174221007 creator A5033472956 @default.
- W3174221007 creator A5067070506 @default.
- W3174221007 creator A5079013516 @default.
- W3174221007 date "2021-06-01" @default.
- W3174221007 modified "2023-09-25" @default.
- W3174221007 title "1022-P: Changes in Excess Mortality among Adults with Diabetes-Related End-Stage Renal Disease: A Comparison between the United States and Australia" @default.
- W3174221007 doi "https://doi.org/10.2337/db21-1022-p" @default.
- W3174221007 hasPublicationYear "2021" @default.
- W3174221007 type Work @default.
- W3174221007 sameAs 3174221007 @default.
- W3174221007 citedByCount "0" @default.
- W3174221007 crossrefType "journal-article" @default.
- W3174221007 hasAuthorship W3174221007A5024475260 @default.
- W3174221007 hasAuthorship W3174221007A5033472956 @default.
- W3174221007 hasAuthorship W3174221007A5067070506 @default.
- W3174221007 hasAuthorship W3174221007A5079013516 @default.
- W3174221007 hasConcept C126322002 @default.
- W3174221007 hasConcept C134018914 @default.
- W3174221007 hasConcept C144024400 @default.
- W3174221007 hasConcept C146357865 @default.
- W3174221007 hasConcept C149923435 @default.
- W3174221007 hasConcept C151730666 @default.
- W3174221007 hasConcept C2779134260 @default.
- W3174221007 hasConcept C3019040382 @default.
- W3174221007 hasConcept C555293320 @default.
- W3174221007 hasConcept C71924100 @default.
- W3174221007 hasConcept C74909509 @default.
- W3174221007 hasConcept C86803240 @default.
- W3174221007 hasConceptScore W3174221007C126322002 @default.
- W3174221007 hasConceptScore W3174221007C134018914 @default.
- W3174221007 hasConceptScore W3174221007C144024400 @default.
- W3174221007 hasConceptScore W3174221007C146357865 @default.
- W3174221007 hasConceptScore W3174221007C149923435 @default.
- W3174221007 hasConceptScore W3174221007C151730666 @default.
- W3174221007 hasConceptScore W3174221007C2779134260 @default.
- W3174221007 hasConceptScore W3174221007C3019040382 @default.
- W3174221007 hasConceptScore W3174221007C555293320 @default.
- W3174221007 hasConceptScore W3174221007C71924100 @default.
- W3174221007 hasConceptScore W3174221007C74909509 @default.
- W3174221007 hasConceptScore W3174221007C86803240 @default.
- W3174221007 hasIssue "Supplement 1" @default.
- W3174221007 hasLocation W31742210071 @default.
- W3174221007 hasOpenAccess W3174221007 @default.
- W3174221007 hasPrimaryLocation W31742210071 @default.
- W3174221007 hasRelatedWork W1563850031 @default.
- W3174221007 hasRelatedWork W2032287785 @default.
- W3174221007 hasRelatedWork W2094113608 @default.
- W3174221007 hasRelatedWork W2167444163 @default.
- W3174221007 hasRelatedWork W2233866314 @default.
- W3174221007 hasRelatedWork W2383009242 @default.
- W3174221007 hasRelatedWork W2415759662 @default.
- W3174221007 hasRelatedWork W2604117027 @default.
- W3174221007 hasRelatedWork W3036934084 @default.
- W3174221007 hasRelatedWork W88627568 @default.
- W3174221007 hasVolume "70" @default.
- W3174221007 isParatext "false" @default.
- W3174221007 isRetracted "false" @default.
- W3174221007 magId "3174221007" @default.
- W3174221007 workType "article" @default.